Skip to main content
Log in

Patients newly diagnosed with multiple myeloma in Ontario, Canada, will have access to funding for treatment with bortezomib

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ortho Biotech Inc.Ontario Government Announces Reimbursement of Velcade* As First-Line Treatment For Newly-diagnosed Blood Cancer Patients. Media Release: 13 May 2009. Available from: URL: http://www.orthobiotech.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patients newly diagnosed with multiple myeloma in Ontario, Canada, will have access to funding for treatment with bortezomib. Pharmacoecon. Outcomes News 579, 14 (2009). https://doi.org/10.2165/00151234-200905790-00036

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905790-00036

Keywords

Navigation